These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21147921)

  • 21. Effect of the deletion of US2 and US3 from herpes simplex virus type 2 on immune responses in the murine vagina following intravaginal infection.
    Inagaki-Ohara K; Iwasaki T; Watanabe D; Kurata T; Nishiyama Y
    Vaccine; 2001 Oct; 20(1-2):98-104. PubMed ID: 11567752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI
    Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical involvement of CD40 in protection against herpes simplex virus infection in a murine model of genital herpes.
    Inagaki-Ohara K; Kawabe T; Hasegawa Y; Hashimoto N; Nishiyama Y
    Arch Virol; 2002; 147(1):187-94. PubMed ID: 11855631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
    Gill N; Rosenthal KL; Ashkar AA
    J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice.
    Thapa M; Carr DJ
    J Virol; 2008 Oct; 82(20):10295-301. PubMed ID: 18684827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role for the CCR5-CCL5 interaction in the preferential migration of HSV-2-specific effector cells to the vaginal mucosa upon nasal immunization.
    Joo S; Suwanto A; Sato A; Nakahashi-Ouchida R; Mori H; Uchida Y; Sato S; Kurashima Y; Yuki Y; Fujihashi K; Kawaguchi Y; Kiyono H
    Mucosal Immunol; 2019 Nov; 12(6):1391-1403. PubMed ID: 31551493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2.
    Zhao X; Deak E; Soderberg K; Linehan M; Spezzano D; Zhu J; Knipe DM; Iwasaki A
    J Exp Med; 2003 Jan; 197(2):153-62. PubMed ID: 12538655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models.
    Visalli RJ; Natuk RJ; Kowalski J; Guo M; Blakeney S; Gangolli S; Cooper D
    Vaccine; 2014 Mar; 32(12):1398-406. PubMed ID: 24462481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective vaccination against genital herpes simplex virus type 2 (HSV-2) infection in mice is associated with a rapid induction of local IFN-gamma-dependent RANTES production following a vaginal viral challenge.
    Harandi AM; Svennerholm B; Holmgren J; Eriksson K
    Am J Reprod Immunol; 2001 Dec; 46(6):420-4. PubMed ID: 11775012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
    Gillgrass AE; Tang VA; Towarnicki KM; Rosenthal KL; Kaushic C
    J Virol; 2005 Mar; 79(5):3117-26. PubMed ID: 15709031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation.
    Thebeau LG; Morrison LA
    J Virol; 2003 Feb; 77(4):2426-35. PubMed ID: 12551980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
    Bettahi I; Zhang X; Afifi RE; BenMohamed L
    Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.
    Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H
    J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nrf2 Negatively Regulates Type I Interferon Responses and Increases Susceptibility to Herpes Genital Infection in Mice.
    Gunderstofte C; Iversen MB; Peri S; Thielke A; Balachandran S; Holm CK; Olagnier D
    Front Immunol; 2019; 10():2101. PubMed ID: 31555293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2.
    McDermott MR; Goldsmith CH; Rosenthal KL; Brais LJ
    J Infect Dis; 1989 Mar; 159(3):460-6. PubMed ID: 2783720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.
    Dobbs ME; Strasser JE; Chu CF; Chalk C; Milligan GN
    J Virol; 2005 Dec; 79(23):14546-54. PubMed ID: 16282454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG
    Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection.
    Carr DJ; Wuest T; Tomanek L; Silverman RH; Williams BR
    Immunology; 2006 Aug; 118(4):520-6. PubMed ID: 16895559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection.
    Johnson AJ; Nelson MH; Bird MD; Chu CF; Milligan GN
    J Reprod Immunol; 2010 Jan; 84(1):8-15. PubMed ID: 19942296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurokinin 1 receptor signaling affects the local innate immune defense against genital herpes virus infection.
    Svensson A; Kaim J; Mallard C; Olsson A; Brodin E; Hökfelt T; Eriksson K
    J Immunol; 2005 Nov; 175(10):6802-11. PubMed ID: 16272337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.